Novo Nordisk · 1 day ago
Internship - Medical Affairs Training & Resources
Plainsboro, NJ
Internship
Onsite
Intern
$52K/yr - $89K/yrNovo Nordisk is a global pharmaceutical company focused on improving patients' quality of life. The Medical Affairs Training & Resources intern will support the Medical Affairs Program Development & Training directors in streamlining resources, enhancing onboarding curricula, and creating strategic communication points for therapeutic resources.
BiotechnologyHealth CareMedicalPharmaceutical
No H1B
Responsibilities
Work with the Medical Affairs Program Development & Training directors to streamline therapeutic resources
Support onboarding curricula
Ensure resources provide strategic communication points
Expand utilization of learning systems
Support creation of resources as needed
Qualification
Required
Must be a current student enrolled or recently graduated (graduation date no earlier than May 2026) at/from an accredited college or university pursuing at least a bachelor's degree
Conscientious self-starter with good organizational skills, project management skills and attention to detail
Ability to balance multiple projects and priorities, must be able to multi-task
Strong interpersonal communication and ability to collaborate with teams; must effectively operate independently, across functional lines, and with internal customers
Demonstrated personal initiative, self-motivation, flexibility, adaptability and willingness to learn
Proficient in Microsoft Office Tools including Word, Excel, PowerPoint, etc
Preferred
A completed or in progress undergraduate, graduate, or doctoral degree in Pharmacy, Learning and Development, Systems or a related discipline preferred
Strong academic record with a preferred cumulative GPA of 3.0 or higher
Company
Novo Nordisk
Novo Nordisk is a healthcare company that produces and distributes insulin and other diabetes drugs to treat chronic diseases.
Founded in 1923
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$22M2018-12-05Post Ipo Equity· $22M
1981-07-09IPO
Leadership Team
Lars Fruergaard Jørgensen
President and CEO
Lars Sorensen
President & CEO
Recent News
Labiotech UG
2026-01-24
bloomberglaw.com
2026-01-24
Company data provided by crunchbase